News
RSMDF
20.06
NaN%
--
Resmed Announces Agreement to Sell MatrixCare Business
Barchart · 07/07 15:30
ResMed: GLP-1 Threats Are Overstated
Seeking Alpha · 06/11 11:05
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Seeking Alpha · 05/11 20:30
10 Dividend Growth Stocks: May 2025
Seeking Alpha · 05/09 13:00
ResMed Inc. Reports Quarterly Results for the Period Ended March 31, 2026
Press release · 05/02 07:30
ResMed expects FY 2026 gross margin of 62%-63% as it plans $175M+ Q4 buybacks and targets June 1 close for $340M Noctrix deal
Seeking Alpha · 05/01 00:22
I Shared 42 Sell Ratings In 2019. Here Is How They Have Performed Long-Term.
Seeking Alpha · 04/07 16:24
Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Barchart · 04/01 15:05
ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating
Seeking Alpha · 03/16 16:45
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Barchart · 03/03 02:00
ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell
Seeking Alpha · 02/01 05:54
ResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments
Seeking Alpha · 01/30 01:24
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Barchart · 01/08 15:05
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Barchart · 12/18/2025 15:05
Diamond Hill Long-Short Strategy: Q3 2025 Longs And Shorts
Seeking Alpha · 11/19/2025 01:30
ResMed outlines high single-digit growth targets for mask segment as new fabric mask launches drive innovation
Seeking Alpha · 10/31/2025 02:17
Edwards Lifesciences: Inflection Incoming, But When?
Seeking Alpha · 10/14/2025 18:36
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
Barchart · 10/09/2025 15:05
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
Barchart · 09/16/2025 15:05
Weekly Report: what happened at RSMDF last week (0908-0912)?
Weekly Report · 09/15/2025 11:54
More
Webull provides a variety of real-time RSMDF stock news. You can receive the latest news about Resmed through multiple platforms. This information may help you make smarter investment decisions.
About RSMDF
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.